Visualitza per autor "Borbath, Ivan"
Ara mostrant els elements 1-2 d 2
-
Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors
Robbrecht, Debbie; Grob, Jean-Jacques; Bechter, Oliver; Simonelli, Matteo; Doger, B.; Borbath, Ivan; Doger, B; GARRALDA, Elena (Wiley, 2024-02) -
Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results
Pavel, Marianne E.; Ćwikła, Jarosław B.; Lombard-Bohas, Catherine; Shah, Tahir; Pape, Ulrich F.; Capdevila Castillon, Jaume; Borbath, Ivan (Elsevier, 2021-11)